RD Biotech

RD-Biotech is a CRO/CDMO in biotechnology. It provides custom molecular biology, immunology and cell engineering services for research, preclinical and clinical programmes, from feasibility studies to production of plasmid DNA (including GMP grade), monoclonal and recombinant antibodies, recombinant proteins and cell lines. It also sells ready-to-use reagents, cells, ELISA kits and rabies antibodies for research, diagnostic and preclinical use.

Its customers include pharmaceutical, vaccine, biotech, cell and gene therapy, research institute, environmental, life sciences and agri-food organisations. Revenue comes from contract development and production services and from its catalogue of reagents and kits. The company reports having delivered to more than 40 countries.

RD-Biotech was founded in 2002 and is headquartered in Besançon, France, where its GMP-certified production facilities are located. It is a sister company of MImAbs. The company is recruiting technicians and project managers for bioproduction and plasmid process development in Besançon.

Product: Contract R&D and GMP/non-GMP manufacturing of plasmid DNA, antibodies, recombinant proteins and cell lines, plus catalogue reagents and ELISA kits.